Katrina F Flores1, Gretchen Bandoli1,2, Christina D Chambers1,2, Michael Schatz3, Kristin Palmsten4. 1. Department of Pediatrics, University of California, La Jolla, San Diego, CA, USA. 2. Department of Family Medicine and Public Health, University of California, La Jolla, San Diego, CA, USA. 3. Department of Allergy, Kaiser Permanente Medical Center, San Diego, CA, USA. 4. HealthPartners Institute, Minneapolis, MN, USA.
Abstract
Objective: To provide updated prevalence estimates of asthma and asthma medication use for women of childbearing age in the United States. Methods: Using data from 11,383 women aged 18-44, including a subset of 1,245 pregnant women, enrolled in the National Health and Nutrition Examination Survey (2001-2016), we assessed the age-adjusted prevalence of self-reported diagnosed asthma. For women aged 18-44, we stratified by year, demographics, and other characteristics. Furthermore, we assessed asthma medication use among women aged 18-44 with asthma. Results: After age-adjustment, 9.9% (95% confidence interval (CI) 9.2%, 10.7%) of women aged 18-44 and 10.9% (95% CI 7.2%, 14.6%) of pregnant women reported having asthma. Asthma prevalence was highest in 2015-2016 (12.0% 95% CI 9.8%, 14.3%) and lowest in 2003-2004 (8.6% 95% CI 6.4%, 10.8%). Women aged 18-44 with Medicaid or State Children's Health Insurance Program insurance coverage (16.8% 95% CI 14.5%, 19.2%), obesity (14.4% 95% CI 12.9%, 15.8%), diabetes (18.7% 95% CI 12.1%, 25.2%), hypertension (16.6% 95% CI 14.2%, 19.0%), and current smokers (12.8% 95% CI 11.4%, 14.2%) had the highest asthma prevalence. Of women with asthma, 38.3% (95% CI 34.5%, 42.1%) reported using asthma medications in the past 30 days.Conclusions: Among women of childbearing ages, asthma burden varies across demographic and clinical characteristics and has increased in recent years.
Objective: To provide updated prevalence estimates of asthma and asthma medication use for women of childbearing age in the United States. Methods: Using data from 11,383 women aged 18-44, including a subset of 1,245 pregnant women, enrolled in the National Health and Nutrition Examination Survey (2001-2016), we assessed the age-adjusted prevalence of self-reported diagnosed asthma. For women aged 18-44, we stratified by year, demographics, and other characteristics. Furthermore, we assessed asthma medication use among women aged 18-44 with asthma. Results: After age-adjustment, 9.9% (95% confidence interval (CI) 9.2%, 10.7%) of women aged 18-44 and 10.9% (95% CI 7.2%, 14.6%) of pregnant women reported having asthma. Asthma prevalence was highest in 2015-2016 (12.0% 95% CI 9.8%, 14.3%) and lowest in 2003-2004 (8.6% 95% CI 6.4%, 10.8%). Women aged 18-44 with Medicaid or State Children's Health Insurance Program insurance coverage (16.8% 95% CI 14.5%, 19.2%), obesity (14.4% 95% CI 12.9%, 15.8%), diabetes (18.7% 95% CI 12.1%, 25.2%), hypertension (16.6% 95% CI 14.2%, 19.0%), and current smokers (12.8% 95% CI 11.4%, 14.2%) had the highest asthma prevalence. Of women with asthma, 38.3% (95% CI 34.5%, 42.1%) reported using asthma medications in the past 30 days.Conclusions: Among women of childbearing ages, asthma burden varies across demographic and clinical characteristics and has increased in recent years.
Entities:
Keywords:
asthma; epidemiology; pregnancy; prescriptions; prevalence; women’s health
Authors: Helen L Kwon; Elizabeth W Triche; Kathleen Belanger; Michael B Bracken Journal: Immunol Allergy Clin North Am Date: 2006-02 Impact factor: 3.479
Authors: Clifford L Johnson; Ryne Paulose-Ram; Cynthia L Ogden; Margaret D Carroll; Deanna Kruszon-Moran; Sylvia M Dohrmann; Lester R Curtin Journal: Vital Health Stat 2 Date: 2013-09
Authors: Rachel Enriquez; Marie R Griffin; Kecia N Carroll; Pingsheng Wu; William O Cooper; Tebeb Gebretsadik; William D Dupont; Edward F Mitchel; Tina V Hartert Journal: J Allergy Clin Immunol Date: 2007-07-20 Impact factor: 10.793
Authors: Holly Michelle Crowe; Lauren Anne Wise; Amelia Kent Wesselink; Kenneth Jay Rothman; Ellen Margrethe Mikkelsen; Henrik Toft Sørensen; Allan Jay Walkey; Elizabeth Elliott Hatch Journal: Clin Epidemiol Date: 2020-06-08 Impact factor: 4.790
Authors: Meredith M Howley; Eleni A Papadopoulos; Carla M Van Bennekom; Alissa R Van Zutphen; Suzan L Carmichael; JeanPierre W Munsie; Michele L Herdt; Marilyn L Browne Journal: J Allergy Clin Immunol Pract Date: 2020-07-31